nodes	percent_of_prediction	percent_of_DWPC	metapath
LULICONAZOLE—CYP2C19—Bortezomib—hematologic cancer	0.0625	0.069	CbGbCtD
LULICONAZOLE—CYP2C19—Thalidomide—hematologic cancer	0.0545	0.0601	CbGbCtD
LULICONAZOLE—CYP2C19—Teniposide—hematologic cancer	0.052	0.0573	CbGbCtD
LULICONAZOLE—CYP3A4—Bexarotene—hematologic cancer	0.0493	0.0544	CbGbCtD
LULICONAZOLE—CYP2C19—Ifosfamide—hematologic cancer	0.048	0.0529	CbGbCtD
LULICONAZOLE—CYP3A4—Lomustine—hematologic cancer	0.0459	0.0506	CbGbCtD
LULICONAZOLE—CYP3A4—Busulfan—hematologic cancer	0.0459	0.0506	CbGbCtD
LULICONAZOLE—CYP2C19—Imatinib—hematologic cancer	0.0458	0.0505	CbGbCtD
LULICONAZOLE—CYP3A4—Thiotepa—hematologic cancer	0.0409	0.0451	CbGbCtD
LULICONAZOLE—CYP3A4—Methoxsalen—hematologic cancer	0.0318	0.0351	CbGbCtD
LULICONAZOLE—Tinea pedis—Nilotinib—hematologic cancer	0.0306	0.328	CcSEcCtD
LULICONAZOLE—CYP3A4—Bortezomib—hematologic cancer	0.0302	0.0334	CbGbCtD
LULICONAZOLE—CYP2C19—Prednisone—hematologic cancer	0.0302	0.0333	CbGbCtD
LULICONAZOLE—CYP3A4—Daunorubicin—hematologic cancer	0.0289	0.0319	CbGbCtD
LULICONAZOLE—CYP3A4—Cytarabine—hematologic cancer	0.0255	0.0281	CbGbCtD
LULICONAZOLE—CYP3A4—Teniposide—hematologic cancer	0.0251	0.0277	CbGbCtD
LULICONAZOLE—CYP3A4—Ifosfamide—hematologic cancer	0.0232	0.0256	CbGbCtD
LULICONAZOLE—CYP3A4—Imatinib—hematologic cancer	0.0222	0.0244	CbGbCtD
LULICONAZOLE—CYP3A4—Ruxolitinib—hematologic cancer	0.0209	0.023	CbGbCtD
LULICONAZOLE—CYP3A4—Nilotinib—hematologic cancer	0.0201	0.0222	CbGbCtD
LULICONAZOLE—CYP3A4—Vinorelbine—hematologic cancer	0.02	0.022	CbGbCtD
LULICONAZOLE—CYP2C19—Dexamethasone—hematologic cancer	0.0188	0.0208	CbGbCtD
LULICONAZOLE—CYP3A4—Triamcinolone—hematologic cancer	0.0183	0.0201	CbGbCtD
LULICONAZOLE—CYP3A4—Dasatinib—hematologic cancer	0.0178	0.0196	CbGbCtD
LULICONAZOLE—CYP3A4—Mitoxantrone—hematologic cancer	0.0176	0.0194	CbGbCtD
LULICONAZOLE—CYP3A4—Betamethasone—hematologic cancer	0.0157	0.0173	CbGbCtD
LULICONAZOLE—CYP3A4—Prednisolone—hematologic cancer	0.0155	0.017	CbGbCtD
LULICONAZOLE—CYP3A4—Prednisone—hematologic cancer	0.0146	0.0161	CbGbCtD
LULICONAZOLE—CYP3A4—Irinotecan—hematologic cancer	0.0138	0.0153	CbGbCtD
LULICONAZOLE—CYP3A4—Vinblastine—hematologic cancer	0.0123	0.0136	CbGbCtD
LULICONAZOLE—CYP3A4—Vincristine—hematologic cancer	0.0121	0.0133	CbGbCtD
LULICONAZOLE—CYP3A4—Etoposide—hematologic cancer	0.0111	0.0122	CbGbCtD
LULICONAZOLE—CYP3A4—Dexamethasone—hematologic cancer	0.00911	0.0101	CbGbCtD
LULICONAZOLE—CYP3A4—Doxorubicin—hematologic cancer	0.00756	0.00834	CbGbCtD
LULICONAZOLE—Cellulitis—Clofarabine—hematologic cancer	0.00417	0.0446	CcSEcCtD
LULICONAZOLE—Cellulitis—Daunorubicin—hematologic cancer	0.00417	0.0446	CcSEcCtD
LULICONAZOLE—Cellulitis—Pentostatin—hematologic cancer	0.00415	0.0444	CcSEcCtD
LULICONAZOLE—Cellulitis—Anagrelide—hematologic cancer	0.00415	0.0444	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Daunorubicin—hematologic cancer	0.00375	0.0401	CcSEcCtD
LULICONAZOLE—Cellulitis—Bexarotene—hematologic cancer	0.00343	0.0367	CcSEcCtD
LULICONAZOLE—Cellulitis—Imatinib—hematologic cancer	0.00315	0.0338	CcSEcCtD
LULICONAZOLE—Cellulitis—Cladribine—hematologic cancer	0.0031	0.0332	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Bexarotene—hematologic cancer	0.00309	0.033	CcSEcCtD
LULICONAZOLE—Cellulitis—Vinblastine—hematologic cancer	0.00297	0.0318	CcSEcCtD
LULICONAZOLE—Cellulitis—Lenalidomide—hematologic cancer	0.00275	0.0294	CcSEcCtD
LULICONAZOLE—Cellulitis—Bortezomib—hematologic cancer	0.00253	0.0271	CcSEcCtD
LULICONAZOLE—Cellulitis—Thalidomide—hematologic cancer	0.00228	0.0244	CcSEcCtD
LULICONAZOLE—Cellulitis—Alitretinoin—hematologic cancer	0.00217	0.0232	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Thiotepa—hematologic cancer	0.00212	0.0227	CcSEcCtD
LULICONAZOLE—Cellulitis—Gemcitabine—hematologic cancer	0.00198	0.0212	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Alitretinoin—hematologic cancer	0.00195	0.0209	CcSEcCtD
LULICONAZOLE—Cellulitis—Cisplatin—hematologic cancer	0.00185	0.0198	CcSEcCtD
LULICONAZOLE—Cellulitis—Etoposide—hematologic cancer	0.00169	0.0181	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Triamcinolone—hematologic cancer	0.00138	0.0148	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Betamethasone—hematologic cancer	0.00125	0.0134	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Dexamethasone—hematologic cancer	0.00125	0.0134	CcSEcCtD
LULICONAZOLE—Cellulitis—Epirubicin—hematologic cancer	0.00095	0.0102	CcSEcCtD
LULICONAZOLE—Cellulitis—Doxorubicin—hematologic cancer	0.000879	0.00941	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Epirubicin—hematologic cancer	0.000854	0.00914	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Doxorubicin—hematologic cancer	0.00079	0.00845	CcSEcCtD
